Education Act

Greenberg Traurig Grows FDA Practice in Phoenix; Adds Peter Arhangelsky

Retrieved on: 
Friday, February 16, 2024

PHOENIX, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP continues to grow its Health Care & FDA Practice in Arizona with the addition of Peter A. Arhangelsky as shareholder.

Key Points: 
  • Global law firm Greenberg Traurig, LLP continues to grow its Health Care & FDA Practice in Arizona with the addition of Peter A. Arhangelsky as shareholder
    PHOENIX, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP continues to grow its Health Care & FDA Practice in Arizona with the addition of Peter A. Arhangelsky as shareholder.
  • Arhangelsky guides businesses that are regulated by the U.S. Food and Drug Administration (FDA) through both regulatory compliance and litigation matters.
  • Arhangelsky's practice complements that of Justin J. Prochnow , co-chair of the Food, Beverage & Agribusiness Group , who focuses on regulatory matters.
  • "Previously, I worked with Peter as co-counsel on a matter, and I just knew he would be an excellent addition to Greenberg Traurig substantively and culturally," Prochnow said.

Sarasota Voice Over Coach John Burr Elevates Aspiring Talent

Retrieved on: 
Thursday, January 11, 2024

Sarasota, Florida, Jan. 11, 2024 (GLOBE NEWSWIRE) -- In the world of voice acting, one name stands out: John Burr, Sarasota's esteemed voice over coach.

Key Points: 
  • Sarasota, Florida, Jan. 11, 2024 (GLOBE NEWSWIRE) -- In the world of voice acting, one name stands out: John Burr, Sarasota's esteemed voice over coach.
  • With a career spanning more than 35 years in the entertainment industry, John Burr Voice Dynamics has been the driving force behind successful voice over careers.
  • Today, he not only nurtures local talent from his Suncoast studio, but also extends his guidance to aspiring voice artists across the nation.
  • John's journey in voice coaching is captured in his book, The Voice Over Actor's Handbook: How to Analyze, Interpret, and Deliver Scripts.

Elevating the Voices of Creative Professionals: Report & Quote Book

Retrieved on: 
Wednesday, January 3, 2024

Elevating the Voices of Creative Professionals: Report & Quote Book“Most are blue collar, working class voice actors who are working 40 plus hours a week.

Key Points: 

Elevating the Voices of Creative Professionals: Report & Quote Book

  • “Most are blue collar, working class voice actors who are working 40 plus hours a week.
  • Over 60% of the voice actors are located outside of LA and New York.
  • We’re not anti-tech or anti-AI, as many have said before.”   There are many perspectives on generative AI.


The editor of a science fiction and fantasy magazine 
A software developer and contributor to free and open source software projects 
Award winning artists who contributed to movies like Black Panther and Jurassic World along with video games like The Elder Scrolls 

  • While the benefits or risks of new technologies are being debated by policymakers, these individuals experience the effects of innovation in real-time.
  • October discussion underscored that people have concerns about generative AI that are relevant right now and not hypothetical.   In participants’ own words, generative AI is having profound impacts today.
  • “That's a full-time job.”   Understanding these perspectives could be valuable, not everyone has time to watch the 96-minute video recording or read the 40+ page public transcript.


The report itself – supported by attorneys and technologists across the agency, which summarizes the event in terms of: how participants said their data is being obtained, what harms they said they face, how they view consent defaults, and what they’re doing to address generative AI.  

NJOY Brings Sweeping Litigation Against Illicit Disposable Vapor Manufacturers

Retrieved on: 
Thursday, October 19, 2023

Altria Group, Inc. (Altria) announces today its operating company NJOY, LLC (NJOY) has filed sweeping litigation against 34 foreign and domestic manufacturers, distributors and online retailers of illicit disposable e-vapor products that are unlawfully marketed and sold in the State of California and elsewhere.

Key Points: 
  • Altria Group, Inc. (Altria) announces today its operating company NJOY, LLC (NJOY) has filed sweeping litigation against 34 foreign and domestic manufacturers, distributors and online retailers of illicit disposable e-vapor products that are unlawfully marketed and sold in the State of California and elsewhere.
  • The suit seeks a nation-wide injunction against the import, marketing and sale of these illicit products and significant compensatory and punitive damages.
  • “Today there are two markets – one for those who play by the rules and one for those who flagrantly ignore them.
  • NJOY may add additional manufacturers, distributors and retailers to this complaint and will consider further litigation activity.

University of Houston Law Center unveils three new installations honoring Hispanic and African American legal achievements

Retrieved on: 
Friday, October 13, 2023

HOUSTON, Oct. 13, 2023 /PRNewswire/ -- The University of Houston Law Center commemorates the remarkable achievements of its Hispanic and African American law graduates and faculty with the unveiling of three new displays.

Key Points: 
  • HOUSTON, Oct. 13, 2023 /PRNewswire/ -- The University of Houston Law Center commemorates the remarkable achievements of its Hispanic and African American law graduates and faculty with the unveiling of three new displays.
  • University of Houston Law Center Professor Sandra Guerra Thompson spoke about her late colleague and the dedication of the portrait.
  • '79) and his wife Carol West dedicated the heritage wall to recognize the achievements and contributions of UH Law Center African American alumni and faculty.
  • '79) designated their heritage wall to recognize the outstanding achievements and contributions of Hispanic alumni and faculty at the University of Houston Law Center.

CareDx Announces District Court Judge Bars Natera from Falsely Advertising and Overstating the Scientific Performance of its Prospera Transplant Test

Retrieved on: 
Monday, August 7, 2023

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the United States District Court for the District of Delaware (the “District Court”) issued an injunction prohibiting Natera (Nasdaq: NTRA) from continuing to falsely advertise and overstate the scientific performance of its Prospera transplant test.

Key Points: 
  • CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the United States District Court for the District of Delaware (the “District Court”) issued an injunction prohibiting Natera (Nasdaq: NTRA) from continuing to falsely advertise and overstate the scientific performance of its Prospera transplant test.
  • The injunction follows the July 17, 2023, decision by the District Court to uphold and reaffirm the March 2022 jury verdict finding that Natera (Nasdaq: NTRA) violated the Lanham Act by falsely advertising the scientific performance of its Prospera transplant test.
  • On July 17, 2023, the District Court upheld the jury’s prior decision that Natera made nine false advertising claims about its Prospera kidney transplant test and false advertising comparisons to CareDx’s AlloSure® Kidney to the transplant community.
  • This injunction is a win for the transplant community because patient care and science won over false advertising.

Patriot Pickle, Inc. Admits in Court Filings That Wahlburgers Pickles Contained Artificial Preservative Sodium Benzoate

Retrieved on: 
Thursday, August 3, 2023

BOSTON, Aug. 3, 2023 /PRNewswire/ -- On January 3, 2023, Grillo's Pickles, Inc. filed federal Lanham Act and common law unfair competition claims against Patriot Pickle Inc., ARKK Food Company and Wahlburgers I, LLC for misleading consumers and retailers by labeling and marketing Wahlburgers pickles as "fresh," "all natural" and containing "no preservatives" when, to the contrary, Wahlburgers pickles contained sodium benzoate, an artificial chemical preservative. The misleading labeling of Wahlburgers pickles, combined with the similar packaging and near identical taste to all-natural Grillo's, has harmed Grillo's Pickles by diverting customers away from the brand and to Wahlburgers. Simultaneously, Grillo's filed a preliminary injunction motion asking the court to order Patriot Pickle to stop falsely advertising Wahlburgers pickles. 

Key Points: 
  • The misleading labeling of Wahlburgers pickles, combined with the similar packaging and near identical taste to all-natural Grillo's, has harmed Grillo's Pickles by diverting customers away from the brand and to Wahlburgers.
  • Simultaneously, Grillo's filed a preliminary injunction motion asking the court to order Patriot Pickle to stop falsely advertising Wahlburgers pickles.
  • Since then, Patriot Pickle has admitted in court filings that its Wahlburgers pickles did, in fact, contain the artificial preservative sodium benzoate.
  • According to Patriot Pickle, Wahlburgers pickles shipped before Patriot Pickle took corrective action to remedy the sodium benzoate issue are now, "...past their 'best by' date and are unlikely to be on store shelves."

Academic and vocational education divides students – radical change could make education more equal

Retrieved on: 
Tuesday, July 25, 2023

Rishi Sunak has pledged to limit “rip-off” university courses and boost apprenticeships – diverting school students away from university and towards vocational education.

Key Points: 
  • Rishi Sunak has pledged to limit “rip-off” university courses and boost apprenticeships – diverting school students away from university and towards vocational education.
  • Labour leader Keir Starmer has spoken of his desire to end “the snobbery that looks down on vocational education” through curriculum reform.
  • A more radical proposal could see the two paths integrated throughout the school system – with all students picking from both academic and vocational subjects.

Separate paths

    • Which school children went to was decided by a test taken at age 11.
    • In the early 1950s, only around 20% of children went to grammar schools.
    • But the idea of separate academic and vocational pathways has remained to this day in post-16 education, with separate qualifications available.
    • But parents and teachers – whose opinions were valuable to the students – still saw academic qualifications as the better option.

Changing the system

    • More support is needed for teachers if they are to provide even-handed advice to students and their families.
    • Vocational pathways should be recommended because this is the best option for the student, rather than a second-best option for those not as good at exams.
    • However, excluding young people with appropriate vocational qualifications maintains the hierarchies that suggest some types of knowledge are more valuable than others.
    • Now that all young people have to stay in education or training until they are 18, a system like this could feasibly be put in place.

CareDx Applauds District Court Decision to Uphold Jury Verdict that Natera Falsely Advertised its Prospera Transplant Test

Retrieved on: 
Tuesday, July 18, 2023

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the United States District Court for the District of Delaware (the “District Court”) decision upheld and reaffirmed the March 2022 jury verdict finding that Natera (Nasdaq: NTRA) violated the Lanham Act by falsely advertising the scientific performance of its Prospera transplant test.

Key Points: 
  • CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the United States District Court for the District of Delaware (the “District Court”) decision upheld and reaffirmed the March 2022 jury verdict finding that Natera (Nasdaq: NTRA) violated the Lanham Act by falsely advertising the scientific performance of its Prospera transplant test.
  • On July 17, 2023, the District Court upheld the jury’s prior decision on all of the nine counts, and where the jury found that Natera made false advertising claims about its Prospera kidney transplant test and false advertising comparisons to CareDx’s AlloSure® Kidney.
  • While the District Court did not uphold the monetary damages awarded by the jury, which CareDx intends to appeal, the District Court reaffirmed that Natera falsely advertised its Prospera test to the transplant community.
  • CareDx is proud to be 100 percent committed to transplant patients and to being a leader in transplant innovation.

Court Issues Favorable Ruling for Natera in False Advertising Trial Against CareDx; Eliminates all Damages

Retrieved on: 
Monday, July 17, 2023

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that the United States District Court for the District of Delaware issued a decision in favor of Natera in the false advertising case brought by CareDx, Inc.

Key Points: 
  • Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that the United States District Court for the District of Delaware issued a decision in favor of Natera in the false advertising case brought by CareDx, Inc.
  • In today’s decision, the Court reversed findings returned by a jury in March 2022 and ruled that CareDx is not entitled to any damages.
  • The decision also noted that CareDx showed no evidence that any person was deceived by or relied on any of the advertisements at issue in the case.
  • Separately, the jury’s March 2022 verdict that CareDx engaged in false advertising against Natera, in violation of the Lanham Act, remains in place.